Hostname: page-component-8448b6f56d-c47g7 Total loading time: 0 Render date: 2024-04-16T21:02:09.060Z Has data issue: false hasContentIssue false
  • English
  • Français

Detection and Treatment of Antibiotic-Resistant Bacterial Carriage in a Surgical Intensive Care Unit: A 6-Year Prospective Survey

Published online by Cambridge University Press:  21 June 2016

Gilles Troché ,
Luc-Marie Toly ,
Michèle Guibert  and
Jean-Fabien Zazzo
Gilles Troché*
Affiliation:
Unité de réanimation chirurgicale, département d'anesthésie-réanimation, hôpital Antoine Béclère, Clamart, France
Luc-Marie Toly
Affiliation:
Unité de réanimation chirurgicale, département d'anesthésie-réanimation, hôpital Antoine Béclère, Clamart, France
Michèle Guibert
Affiliation:
Unité de réanimation chirurgicale, département d'anesthésie-réanimation, hôpital Antoine Béclère, Clamart, France
Jean-Fabien Zazzo
Affiliation:
Unité de réanimation chirurgicale, département d'anesthésie-réanimation, hôpital Antoine Béclère, Clamart, France
*
Medico-surgical Intensive Care Unit, André Mignot Hospital, 177 rue de Versailles, 78157 Le Chesnay Cedex, France. gtroche.beclere@invivo.edu
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

To describe, during a 6-year period, multidrug-resistant bacterial carriage in an intensive care unit (ICU).

Design:

Prospective survey of 2,235 ICU patients with methicillin-resistant Staphylococcus aureus (MRSA) and extended-spectrum beta-lactamase–producing Enterobacteriaceae (ESBL-E).

Setting:

A surgical ICU in a tertiary-care teaching hospital.

Patients:

All admitted patients.

Interventions:

Nasal and rectal swabs were performed at admission and weekly thereafter. There was nasal application of mupirocin for MRSA carriers and selective digestive decontamination with local antibiotics for ESBL-E carriers.

Results:

The swab compliance rate was 82% at admission and 51% during ICU stay. The rates of MRSA carriage or infection were 4.2 new cases per 100 admissions and 7.9 cases per 1,000 patient-days during ICU stay. The rates of ESBL-E carriage or infection were 0.4 new case per 100 admissions and 3.9 cases per 1,000 patient-days during ICU stay. Importation of MRSA increased significantly over time from 3.2 new cases per 100 admissions during the first 3 years to 5.5 during the last 3 years. The rate of ICU-acquired ESBL-E decreased from 5.5 cases per 1,000 patient-days during the first 3 years to 1.9 cases during the last 3 years. Nasal and digestive decontamination had low efficacy in eradicating carriage.

Conclusions:

MRSA remained poorly controlled throughout the hospital and was not just a problem in the ICU. MRSA thus requires more effective measures throughout the hospital. ESBL-E was mainly an ICU pathogen and our approach resulted in a clear decrease in the rate of acquisition in the ICU over time.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 26 , Issue 2 , February 2005 , pp. 161 - 165
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2005

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Lucet, JC, Chevret, S, Decre, D, et al.Outbreak of multiply resistant Enterobacteriaceae in an intensive care unit: epidemiology and risk factors for acquisition. Clin Infect Dis 1996;22:430–436.CrossRefGoogle Scholar
2.Asensio, A, Guerrero, A, Quereda, C, Lizan, M, Martinez-Ferrer, M. Colonization and infection with methicillin-resistant Staphylococcus aureus: associated factors and eradication. Infect Control Hosp Epidemiol 1996;17:20–28.CrossRefGoogle ScholarPubMed
3.Nathens, AB, Marshall, JC. Selective decontamination of the digestive tract in surgical patients: a systematic review of evidence. Arch Surg 1999;134:170–177.CrossRefGoogle Scholar
4.Decre, D, Gachot, B, Lucet, JC, Arlet, G, Bergogne-Berezin, E, Regnier, B. Clinical and bacteriologie epidemiology of extended-spectrum beta-lactamase-producing strains of Klebsiella pneumoniae in a medical intensive care unit. Clin Infect Dis 1998;27:834–844.CrossRefGoogle Scholar
5.Albertini, MT, Benoit, C, Berardi, L, et al.Microbiology Surveillance Network of Northern France. Surveillance of methicillin-resistant Staphylococcus aureus (MRSA) and Enterobacteriaceae producing extended-spectrum beta-lactamase (ESBLE) in Northern France: a five-year multicentre incidence study. J Hosp Infect 2002;52:107–113.Google Scholar
6.Dupeyron, C, Campillo, SB, Mangeney, N, Richardet, JP, Leluan, G. Carriage of Staphylococcus aureus and of gram-negative bacilli resistant to third-generation cephalosporins in cirrhotic patients: a prospective assessment of hospital-acquired infections. Infect Control Hosp Epidemiol 2001;22:427–432.CrossRefGoogle ScholarPubMed
7.Girou, E, Pujade, G, Legrand, P, Cizeau, F, Brun-Buisson, C. Selective screening of carriers for control of methicillin-resistant Staphylococcus aureus (MRSA) in high-risk hospital areas with a high level of endemic MRSA. Clin Infect Dis 1998;27:543–550.CrossRefGoogle ScholarPubMed
8.Pena, C, Pujol, M, Ricart, A, et al.Risk factors for faecal carriage of Klebsiella pneumoniae producing extended spectrum beta-lactamase (ESBL-KP) in the intensive care unit. J Hosp Infect 1997;35:9–16.CrossRefGoogle ScholarPubMed
9.Merrer, J, Santoli, F, Appere de Vecchi, C, Tran, B, De Jonghe, B, Outin, H. “Colonization pressure” and risk of acquisition of methicillin-resistant Staphylococcus aureus in a medical intensive care unit. Infect Control Hosp Epidemiol 2000;21:718–723.CrossRefGoogle Scholar
10.Papia, G, Louie, M, Traila, A, Johnson, C, Collins, V, Simor, AE. Screening high-risk patients for methicillin-resistant Staphylococcus aureus on admission to the hospital: is it cost effective? Infect Control Hosp Epidemiol 1999;20:473–477.CrossRefGoogle Scholar
11.Troillet, N, Carmeli, Y, Samore, MH, et al.Carriage of methicillin-resistant Staphylococcus aureus at hospital admission. Infect Control Hosp Epidemiol 1998;19:181–185.CrossRefGoogle ScholarPubMed
12.Jernigan, GA, Clemence, MA, Stott, GA, et al.Control of methicillin-resistant Staphylococcus aureus at a university hospital: one decade later. Infect Control Hosp Epidemiol 1995;16:686–696.CrossRefGoogle Scholar
13.Fierobe, L, Decré, D, Mùller, C, et al.Methicillin-resistant Staphylococcus aureus as a causative agent of postoperative intraabdominal infection: relation to nasal colonization. Clin Infect Dis 1999;29:1231–1238.CrossRefGoogle ScholarPubMed
14.Salgado, CD, Farr, BM, Calfee, DP. Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis 2003;36:131–139.CrossRefGoogle ScholarPubMed
15.Harbarth, S, Liassine, N, Dharan, S, Herrault, P, Auckenthaler, R, Pittet, D. Risk factors for persistent carriage of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2000;31:1380–1385.CrossRefGoogle ScholarPubMed
16.Miller, MA, Dascal, A, Portnoy, J, Mendelson, J. Development of mupirocin resistance among methicillin-resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment. Infect Control Hosp Epidemiol 1996;17:811–813.CrossRefGoogle ScholarPubMed
17.Vasquez, JE, Walker, ES, Franzus, BW, Overbay, BK, Reagan, DR, Sarubbi, FA. The epidemiology of mupirocin resistance among methicillin-resistant Staphylococcus aureus at a Veterans' Affairs hospital. Infect Control Hosp Epidemiol 2000;21:459–464.CrossRefGoogle Scholar
18.Dupeyron, C, Campillo, B, Bordes, M, Faubert, E, Richardet, JP, Mangeney, N. A clinical trial of mupirocin in the eradication of methicillin resistant Staphylococcus aureus nasal carriage in a digestive disease unit. J Hosp Infect 2002;52:281–287.CrossRefGoogle Scholar
19.Doebbeling, BN, Breneman, DL, Neu, HC, et al.Elimination of Staphylococcus aureus nasal carriage in health care workers: analysis of six clinical trials with calcium mupirocin ointment. The Mupirocin Collaborative Study Group. Clin Infect Dis 1993;17:466–474.CrossRefGoogle ScholarPubMed
20.Rogers, CJ, van Saene, HK, Suter, PM, Horner, R, Orme, ML. Infection control in critically ill patients: effects of selective decontamination of the digestive tract. American Journal of Hospital Pharmacology 1994;51:631–648.Google ScholarPubMed